Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilization cycle

被引:28
作者
Gartner, B
Moreno, C
Marinaro, A
Remohí, J
Simón, C
Pellicer, A
机构
[1] Inst Valenciano Infertil, Valencia 46020, Spain
[2] Univ Valencia, Sch Med, Dept Pediat Obstet & Gynaecol, Valencia, Spain
关键词
accidental exposure; healthy newborn; IVF cycle; long-acting GnRHa; pregnancy;
D O I
10.1093/humrep/12.11.2557
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
A case of successful pregnancy in an in-vitro fertilization cycle, in spite of an accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration, is reported. The patient underwent two intracytoplasmic sperm injection cycles with thawed epididymal spermatozoa, in which, due to a pharmacist's mistake, ovarian stimulation was carried out by a combination of long-acting gonadotrophin-releasing hormone agonist (leuprolide depot) and gonadotrophins. A successful singleton pregnancy was achieved after intrauterine embryo transfer with the birth of a healthy boy after 38 weeks. We describe the circumstances and results of this clinical case, as well as reviewing the literature.
引用
收藏
页码:2557 / 2559
页数:3
相关论文
共 26 条
[1]   Pregnancy outcome following exposure to gonadotrophin-releasing hormone analogue during early pregnancy: Comparisons in patients with normal or elevated luteinizing hormone [J].
AbuHeija, AT ;
Fleming, R ;
Yates, RWS ;
Coutts, JRT .
HUMAN REPRODUCTION, 1995, 10 (12) :3317-3319
[2]   INADVERTENT GONADOTROPIN-RELEASING-HORMONE AGONIST (GNRHA) ADMINISTRATION IN THE LUTEAL-PHASE MAY IMPROVE FECUNDITY IN IN-VITRO FERTILIZATION PATIENTS [J].
BALASCH, J ;
MARTINEZ, F ;
JOVE, I ;
CABRE, L ;
COROLEU, B ;
BARRI, PN ;
VANRELL, JA .
HUMAN REPRODUCTION, 1993, 8 (07) :1148-1151
[3]   OUTCOME OF INADVERTENT ADMINISTRATION OF A GONADOTROPIN-RELEASING-HORMONE AGONIST (BUSERELIN) IN EARLY-PREGNANCY [J].
CAHILL, DJ ;
FOUNTAIN, SA ;
FOX, R ;
FLEMING, CF ;
BRINSDEN, PR ;
HULL, MGR .
HUMAN REPRODUCTION, 1994, 9 (07) :1243-1246
[4]  
CASPER RF, 1979, SCIENCE, V205, P408, DOI 10.1126/science.377491
[5]  
CASPI E, 1989, FERTIL STERIL, V51, P95
[6]  
COHEN J, 1988, ANN NY ACAD SCI, V8, P988
[7]  
GILSALOM M, 1995, 7 NAT C ANDR BILB SP
[8]   FETAL-OUTCOME FOLLOWING INADVERTENT ADMINISTRATION OF LONG-ACTING DTRP6 GNRH MICROCAPSULES DURING PREGNANCY - A CASE-REPORT [J].
GOLAN, A ;
RONEL, R ;
HERMAN, A ;
WEINRAUB, Z ;
SOFFER, Y ;
CASPI, E .
HUMAN REPRODUCTION, 1990, 5 (01) :123-124
[9]  
HAPP J, 1987, SERIES EUROPEAN ORG, V18, P249
[10]   IMPAIRED CORPUS-LUTEUM FUNCTION AND OTHER UNDESIRED RESULTS OF PREGNANCIES ASSOCIATED WITH INADVERTENT ADMINISTRATION OF A LONG-ACTING AGONIST OF GONADOTROPIN-RELEASING-HORMONE [J].
HERMAN, A ;
RONEL, R ;
GOLAN, A ;
NACHUM, H ;
SOFFER, Y ;
CASPI, E .
HUMAN REPRODUCTION, 1992, 7 (04) :465-468